Sort by
Refine Your Search
-
Category
-
Country
-
Program
-
Field
-
10 Apr 2024 Job Information Organisation/Company Institut Curie - Research Center Research Field Medical sciences » Cancer research Researcher Profile Recognised Researcher (R2) Country France
-
“Chemistry and Modelling for Biology of Cancer” at Institut Curie (Orsay) in will be supervised by Dr Guillaume Bort. The project consists in synthesizing theranostic prodrugs for cancer treatment, adapted
-
21 Mar 2024 Job Information Organisation/Company Institut Curie - CNRS Research Field Chemistry Biological sciences » Biology Researcher Profile Recognised Researcher (R2) Leading Researcher (R4
-
experimentalist physicist or biophysicist to work on a cell mechanics project as part of the European "Pushing Cell" project at the CNRS laboratory "Physics of Cells and Cancer" at the Institut Curie in P
-
the Inserm Research Directors personnel at the end of the contract. Strategy of the host institution : The Institut Curie (IC) is a private foundation devoted to the fight against cancer. The hospital complex
-
. Integrated within the PSL University, and close to other major institutions such as the Ecole Normale Supérieure and the Institut Curie, the Collège de France constitutes an exceptional scientific environment
-
and Tissues” as part of a collaborative group led by Prof. Jacques Prost (Institut Curie, France) and Dr. Tetsuya Hiraiwa (Institute of Physics, Academia Sinica, Taiwan). This project will involve
-
CV! Additional comments Join the University of Bordeaux's INNOVTRIAL project and work in a multidisciplinary team comprising BPH, Institut Curie, Institut du Cancer de Montpellier, Institut Bergonié
-
Architecture, Dynamics, and Functions in Aging Cells and Tissues” as part of a collaborative group led by Prof. Jacques Prost (Institut Curie, France) and Dr. Tetsuya Hiraiwa (Institute of Physics, Academia
-
Département de Chimie Moléculaire (equipe I2BM) / Laboratoire Interdisciplinaire de physique (équipe BIOP) | Grenoble, Rhone Alpes | France | 3 months ago
interactions with DNA. Inthis context, we have recently shown, in collaboration with the Institut Curie in Orsay, that this commercial antibody (iMab) is not specificfor i-motif DNA but also binds to cytosine